Here’s Why These Five Stocks Are in Spotlight
U.S. stocks are trading higher ahead of manufacturing data along with new home sales data which is expected tomorrow.
Posts Tagged ‘Mylan Inc. (MYL)’
Is Mylan Inc. (MYL) Going to Burn These Hedge Funds?
Insider Monkey follows around 730 of the best-performing money managers and even though many of them lost money in the last several months, the history shows that they still manage...
Teva Ascends On Allergan Generics Purchase, Mylan NV (MYL) Withdrawal
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) shares reached as high as $83 per share in pre-market trading Monday, or over 18% higher than the stock’s closing price ...
Weight Watchers (WTW)’ Horrid Q1 Not Enough to Stop North Tide Capital From Double Digit Returns
Conan Laughlin’s North Tide Capital posted impressive first quarter returns of 10.1% from its 14 long positions in companies valued at $1 billion or greater.
Charter Oak Partners Management Loves These Stocks
Charter Oak Partners Management is a fundamentally driven Long/Short hedge fund that focuses mainly on equity investments. It was founded by Jerrold N.
Investing in Counteracting Biological and Chemical Agents
Chemical nerve agents have garnered much media coverage recently, but receiving less attention are the companies involved in the development of countermeasures to these and biological...
Dr. Reddy’s Laboratories Limited (ADR) (RDY), Abbott Laboratories (ABT): Positive Outlook for the Generic Version of Depakote ER
Since 1983, Depakote ER has been a good source of revenue for drug manufacturers. The drug is mainly used in the treatment of bipolar disorder, migraines, and seizures.
Mylan Inc. (MYL), GlaxoSmithKline plc (ADR) (GSK), Nationstar Mortgage Holdings Inc (NSM): Three Stocks to Get on Your Watchlist
I follow quite a lot of companies, so the usefulness of a watchlist to me cannot be overstated.
Netflix, Inc. (NFLX), Advanced Micro Devices, Inc. (AMD), Mylan Inc. (MYL): Today’s Three Best Stocks
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis...
Raptor Pharmaceutical Corp. (RPTP), Mylan Inc. (MYL), Forest Laboratories, Inc. (FRX): Will You Adopt This Orphan Drug?
Orphan drug status, which is given to drugs meant for the treatment of rare diseases, offers drug developers a path to faster approval and enhanced market exclusivity.
Is Salix Pharmaceuticals, Ltd. (SLXP) Going to Burn These Hedge Funds?
In the 21st century investor’s toolkit, there are dozens of methods shareholders can use to monitor their holdings.
Do Hedge Funds and Insiders Love Mylan Inc. (MYL)?
To many investors, hedge funds are assumed to be overrated, old financial vehicles of an era lost to time.
Mylan Inc. (MYL), YY Inc (ADR) (YY): Stocks Near 52-Week Highs Worth Selling
Even with the broad-based S&P 500 retracing for three straight days amid worries that the Federal Reserve may begin paring back its monthly bond-buying program as early as next...
Sealed Air Corp (SEE), Mylan Inc. (MYL), Dell Inc. (DELL): Today’s Best Stocks
It's finally Friday, and the S&P 500 is trying its hardest to find a reason to be happy.
Billionaire John Paulson Loves Bank of America Corp (BAC). Why?
Insider Monkey tracks quarterly 13f filings from hundreds of hedge funds, including billionaire John Paulson’s Paulson & Co, and the firm's love of Bank of America Corp (NYSE...
Three Potential Solutions for Pfizer Inc. (PFE)’s Generic Drug Business
The company broke open a bombshell on Monday when it announced that it would break its business into three new divisions -- two focused around drugs, vaccines, and consumer products...
Momenta Pharmaceuticals, Inc. (MNTA) Latest to Take Advantage of Teva Pharmaceutical Industries Ltd (ADR) (TEVA)’s Patent Woes
The United States Court of Appeals is making this one miserable summer for Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA).
Amgen, Inc. (AMGN), Gilead Sciences, Inc. (GILD): Great Pipelines, Unimpressive Fundamentals
Biotechnology medicine manipulates the genetic material of living organisms to produce pharmaceuticals, which in many instances are designed to combat diseases once considered...
Mylan Inc. (MYL), Rite Aid Corporation (RAD): Five Companies That Beat Last Week’s Rate Hike
Last week's new corporate bond issues totaling nearly $17 billion marked four consecutive weeks below $20 billion.
Abbott Laboratories (ABT), Merck & Co., Inc. (MRK): The Proprietary Drug Business Just Got Riskier
A new Supreme Court ruling presents pharmaceutical companies with a tough choice -- stop paying generic-drug producers to withhold generic options from the market, or risk getting...
Hospira, Inc. (HSP), Mylan Inc. (MYL), Actavis Inc (ACT): Is This Hurting Healthcare Company Priced for a Recovery?
Nothing interests a value investor more than bad news. Where there's a lack of enthusiasm, there's usually a cheap stock. Hospira, Inc.
Warner Chilcott Plc (WCRX): Should You Buy Joel Greenblatt’s Latest Pick?
Searching for potential stock investments can be a daunting task.
Undervalued Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Must Enter New Markets
Generic producers are often regarded as the safer players within BioPharma.
UnitedHealth Group Inc. (UNH), Mylan Inc. (MYL): 5 Leading Women in Health Care
Does the house of health care have a glass ceiling? For women looking to advance in the health care industry, that might appear to be the case. Consider that the U.S.
Pfizer Inc. (PFE), Actavis Inc (ACT): Which Generic Drugmaker Is Your Best Buy Today?
Generic-drug makers have considerable tailwinds, making their outperformance in the past year unsurprising.
Questcor Pharmaceuticals Inc (QCOR), Impax Laboratories Inc (IPXL): Two Stocks That Double Your Chances For Big Gains
Virtually every investor is quite familiar with the names of big pharmaceutical giants such as GlaxoSmithKline plc (ADR) (NYSE:GSK), Eli Lilly & Co.
Could Warner Chilcott Plc (WCRX) Receive a Higher Bid?
Recently, Actavis Inc (NYSE:ACT) announced that it would acquire Warner Chilcott Plc (NASDAQ:WCRX) for around $8.5 billion in total consideration.
Is Mylan Inc. (MYL) Going to Burn These Hedge Funds?
Mylan Inc. (NASDAQ:MYL) was in 27 hedge funds' portfolio at the end of March. MYL shareholders have witnessed a decrease in enthusiasm from smart money of late.
Hedge Fund News: Steven Cohen, Omega Advisors, Goldman Sachs Group, Inc. (GS)
Editor's Note: Related Tickers: Goldman Sachs Group, Inc. (NYSE:GS), Citigroup Inc. (NYSE:C), J.C. Penney Company, Inc. (NYSE:JCP), Herbalife Ltd.
Billionaire John Paulson Bought Sprint Nextel Corporation (S), Sold Mylan Inc (MYL) In Q1 2013
Paulson & Co., the hedge fund which notoriously nailed the popping of the housing bubble during the financial crisis (making its founder, John Paulson, a billionaire due to high...
Is Actavis Inc (ACT) a Buy at This Price?
Actavis Inc (NYSE:ACT), the largest generic drug company in the US, just got even bigger.
Raptor Pharmaceutical Corp. (RPTP), AVEO Pharmaceuticals, Inc. (AVEO) & Two FDA Decisions You Can’t Afford to Miss This Week
Last week we focused on five can't-miss earnings reports.
Aegerion Pharmaceuticals, Inc. (AEGR), Raptor Pharmaceutical Corp. (RPTP): Two Orphan Drugmakers With Upcoming Catalysts
Within the next few days, stocks for two orphan drugmakers could either soar or sink. Both Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) and Raptor Pharmaceutical Corp.
Teva Pharmaceutical Industries Ltd (ADR) (TEVA): Will The Transition Be Effective?
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA), a pharmaceuticals company that makes money off of branded drugs as well as generics, is an interesting example of a company...
Pfizer Inc. (PFE), Johnson & Johnson (JNJ): Is Obamacare a Disaster Waiting to Happen for Big Pharma?
Big pharma loves Obamacare, right? After all, the main lobbying group for big pharma, the Pharmaceutical Researchers and Manufacturers of America, or PhRMA, spent $150 million...
Actavis Inc (ACT) Profits Decrease As Acquisition Takes Toll: Teva Pharmaceutical Industries Ltd (ADR) (TEVA), Mylan Inc. (MYL)
U.S. generics firm Actavis Inc (NYSE:ACT), previously Watson Pharmaceuticals, reported a strong jump in its revenues in the fourth quarter and total earnings for 2012.
Three Reasons to Worry and One Theme That Can Outperform: Life Technologies Corp. (LIFE) and More
Occasionally some of my friends ask me why I am hedged and market neutral in my investing. My answer is always the same.
Pfizer Inc. (PFE) and Merck & Co., Inc. (MRK): 2 Dow Stocks We All Need but Shouldn’t Own
Here at The Motley Fool, we believe the best way to invest and maximize returns is by buying strong companies and owning them for a long time.
A Generic Double Whammy: Teva Pharmaceutical Industries Ltd (TEVA), Mylan Inc. (MYL)
Its narcolepsy drug Provigil saw generic competition from Par Pharmaceutical Companies, Inc. (NYSE:PRX) and Mylan Inc.
